年轻人的急性淋巴细胞白血病:什么是前期治疗?
1Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
青少年和年轻成人B细胞急性淋巴细胞白血病 (B-ALL) 患者可以从儿童启发的治疗中受益. 新型疗法和先进的诊断对于弥补B-ALL护理中的剩余结果差距至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床试验 临床试验
背景情况:
- 青少年和年轻成人 (AYA) 患者 (15-39岁) 患有B细胞急性淋巴细胞白血病 (B-ALL) 历史上与儿科患者相比面临着结果差距.
- 虽然儿科启发的疗法改善了结果,但需要进一步的进展,以解决AYA B-ALL治疗中的持续差异.
研究的目的:
- 审查当前的策略和新的治疗方法,以改善AYA B-ALL的结果.
- 突出临床试验和新兴疗法在AYA B-ALL的前期治疗中的作用.
主要方法:
- 对AYA B-ALL.目前临床试验数据和治疗策略的审查.
- 专注于新型药物,包括免疫疗法 (inotuzumab,blinatumomab,CAR T细胞疗法) 和向疗法 (铁氨酸激酶抑制剂).
- 评估先进的诊断工具,如下一代测序用于可测量的残留疾病 (MRD) 评估.
主要成果:
- 几项前期临床试验正在研究新型免疫疗法和向药物的整合到AYA B-ALL的标准化疗骨干中.
- 用于MRD评估的下一代测序能够实现更高层次的风险分层.
- 改进的风险分层正在减少在第一次完全缓解中需要巩固性造血干细胞移植的需要.
结论:
- 将新型免疫疗法和向药物纳入前期治疗方案有望改善AYA B-ALL的结果.
- 先进的MRD检测正在改进治疗决策,并可能减少移植利用率.
- 继续参与临床试验对于AYA B-ALL患者获得尖端疗法至关重要.
更多相关视频
09:09Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation
Published on: November 10, 2017
8.3K
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.4K
相关概念视频
Bone Marrow Sampling and Transplants
333
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
333
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
